A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
NCT01803581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2018-04-05
Summary
The purpose of this study is to compare the efficacy and safety of an insecticide-free head lice product with that of a pyrethrum-based product.
Conditions
- Head Lice
Interventions
- OTHER
-
X92001327
- OTHER
-
RID shampoo
Sponsors & Collaborators
-
Oystershell NV
lead INDUSTRY
Principal Investigators
-
Lidia Serrano · Lice Source Services
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-05
- Primary Completion
- 2013-06-20
- Completion
- 2013-08-12
Countries
- United States
Study Locations
More Related Trials
-
Testing Methylphenidate for Smoking Abstinence
NCT00549640 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia
NCT00320723 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of NicVAX in Smokers Who Want to Quit Smoking
NCT00318383 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
NCT06254001 ·Status: RECRUITING ·Phase: PHASE4
-
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
NCT03960138 ·Status: COMPLETED ·Phase: NA
-
A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation
NCT01304810 ·Status: COMPLETED
-
Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
NCT00995033 ·Status: COMPLETED ·Phase: PHASE2
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
NCT02355665 ·Status: COMPLETED ·Phase: PHASE3
-
User Acceptability of a Nicotine Lactate Delivery System (P3L)
NCT02643693 ·Status: COMPLETED ·Phase: NA
-
Nicotine's Potential Abuse With Menthol
NCT04535362 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction
NCT04210180 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nicotine Patch Pretreatment for Smoking Cessation in PTSD
NCT00625131 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
NCT02681848 ·Status: UNKNOWN
-
Varenicline for Nicotine Vaping Cessation in Adolescents
NCT05367492 ·Status: COMPLETED ·Phase: PHASE4
-
Manipulating Tobacco Constituents in Female Menthol Smokers
NCT02048852 ·Status: COMPLETED ·Phase: NA
-
Smoking Relapse Prevention in Schizophrenia
NCT00320697 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Nicotine Receptor Density & Response to Nicotine Patch
NCT01526005 ·Status: COMPLETED
-
Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
NCT01018394 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
NCT00046813 ·Status: TERMINATED ·Phase: PHASE4
-
Photoirritation and Photoallergic Potential of a New Nicotine Patch
NCT00966901 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy
NCT00882375 ·Status: COMPLETED ·Phase: NA
-
NicVAX/Placebo as an Aid for Smoking Cessation
NCT00836199 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
NCT04188106 ·Status: COMPLETED ·Phase: PHASE4